• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.09% Nasdaq Up 0.98%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.22 Up 0.55(7.17%) Jul 28, 4:00PM EDT
    |After Hours : 8.23 Up 0.01 (0.12%) Jul 28, 7:45PM EDT
    Add to Portfolio
    Prev Close:7.67
    Open:7.89
    Bid:8.23 x 100
    Ask:8.43 x 4000
    1y Target Est:9.25
    Beta:1.6
    Next Earnings Date: 5-Aug-15ARIA Earnings announcement
    Day's Range:7.66 - 8.29
    52wk Range:4.90 - 9.89
    Volume:4,296,577
    Avg Vol (3m):3,325,480
    Market Cap:1.55B
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 7.17%1.55B
    NVSUp 1.23%248.26B
    PFEUp 2.94%217.67B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback